Today’s Sponsored Feature is part of your subscription to the daily AVMA SmartBrief. This feature, produced by SmartBrief and a select group of sponsors, highlights issues, products and services of interest to veterinarians and all those interested in animal health. It also allows for continued free delivery of AVMA SmartBrief. Thank you for your interest.
- The AVMA SmartBrief Team
|
SPONSORED FEATURE |
 |
|
 |
FEATURED ARTICLE |
 |
|
|
FEATURED PRODUCT |
|
|
How to Protect Despite New Geographic Growth
Canine Lyme disease is no longer just a threat to dogs in the Northeast or North-Central U.S. (often called “endemic areas”). Lyme disease is growing fast — infected dogs have been found in all 48 contiguous states.1 In many states, infection is not likely, but dogs living or traveling in the endemic areas and the growing expansion areas are at risk.
Growing geographic risks
Lyme disease is one of the fastest-growing diseases in the U.S. A dog’s risk level depends on where he lives, his overall health and his lifestyle, such as whether he travels a lot or goes hunting.
Dogs are at risk — regardless of breed
When any dog comes in close contact with infected ticks — usually in wildlife areas where mice and deer live — the risk of exposure to Lyme disease is present. Plus, nearly 75% of unvaccinated dogs in endemic areas will eventually test positive.2
Smart — and easy — protection techniques
Canine Lyme disease is largely preventable with vaccination, tick control products and frequent tick checks. Get details now.
|
Vaccination Helps Dogs Stay Free of Lyme Disease
Duramune Lyme® vaccine is proven 92% effective in preventing Lyme disease3:
– The vaccine induces antibodies to a broad array of Borrelia burgdorferi Osps4 — not just one or two
– It targets the Borrelia burgdorferi organism despite its shifting Osp expression
– Duramune Lyme provides a cascade of continuous, uninterrupted protection against Lyme disease5
|
|
About Boehringer Ingelheim Vetmedica, Inc. |
|
|
 The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability, are intrinsic factors in all of Boehringer Ingelheim’s endeavors.
In 2011, Boehringer Ingelheim achieved net sales of about $ 17.1 billion. Research and development expenditure in the business area of prescription medicines corresponds to 23.5% of its net sales.
Learn more at: http://us.boehringer-ingelheim.com and http://twitter.com/boehringerus.
|
|
|
|
RESOURCE CENTER |
 |
|
|
|
FYI |
|
|
Footnotes:
1 Companion Animal Parasite Council, Parasite Prevalence Maps, CAPCvet.org., 2013
2 Richard Ford, DVM, MS, Dipl. ACVIM. Tracking the development of tick-borne diseases, DVM in Focus, June 2002.
3 Levy S. Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. Vet Ther. 2002;3(4):420-424.
4 Levy SA, et al. Confirmation of Presence of Borrelia burgdorferi Outer Surface Protein C Antigen and Production of Antibodies to Borrelia burgdorferi Outer Surface Protein C in Dogs Vaccinated with a Whole-cell Borrelia burgdorferi Bacterin. Intern J Appl Res Vet Med 2010;Vol 8, No. 3, 123-128.
5 With annual vaccination.
Legal:
© 2013 Boehringer Ingelheim Vetmedica, Inc. Duramune and Duramune Lyme are registered trademarks of Boehringer Ingelheim Vetmedica, Inc. All rights reserved.
|
|
|
SMARTBRIEF ARCHIVES: RELATED NEWS |
|
- AVMA Podcast: Lyme disease
Nearly 40 years ago, an unusual cluster of arthritis cases along the Connecticut River, primarily in children, led to the discovery of Lyme disease as a human illness in the U.S. But it’s not just humans who are susceptible to Lyme disease. Clinical signs of Lyme have been recognized in dogs, horses and cattle. So what exactly is Lyme disease, how is it spread, and how can we prevent it … in people and animals? In the latest AVMA Animal Tracks podcast, Dr. Michael Stone, a clinical assistant professor at Tufts Cummings School of Veterinary Medicine, discusses Lyme disease. Listen to the podcast.
- Simple steps to protect pets from disease
A number of internal and external parasites threaten pets’ health, including intestinal parasites, heartworms, fleas and ticks, and more, writes veterinarian Rebekah Frost, but regular veterinary care and preventive treatments can help protect animals. Ticks are of concern for a variety of reasons including the fact that they may infect animals with Lyme disease, which can cause acute and chronic disease in pets. However, veterinarians can help protect animals with tick control and vaccination against Lyme disease. The Observer (Dunkirk, N.Y.) (3/10)
- Lyme disease becomes more prevalent in northern U.S.
Lyme disease incidence rose about 80% in the U.S. from 1992 to 2007, with higher rates in the North, according to a report in the Canadian Medical Association Journal. Geographic changes in prevalence are consistent with the effects of climate change, researchers said. Medscape (free registration) (4/17), MyHealthNewsDaily.com (4/17)
- 16% of Vt. dogs have been exposed to Lyme
Data indicating 16% of Vermont’s dogs have been exposed to Lyme disease is a sign the disease has been underreported in humans, according to physician Richard Horowitz, who says he has treated 12,000 human Lyme disease patients in New York’s Hudson Valley area. “This is an epidemic and the seriousness is not being recognized,” he said. Patients want to pass a law ensuring they will have access to the long courses of antibiotics needed to treat the disease. Vermont Public Radio (4/3)
|
|
 |
|
What is this? |
A Sponsored Feature is an advertorial that includes valuable content provided by the sponsor and editorial materials from SmartBrief’s archives. This Sponsored Feature does not represent an endorsement by the AVMA or SmartBrief, Inc. of the products and services offered. If you unsubscribe from this Sponsored Feature, you will not be unsubscribing from all other editions of the Animal Health SmartBrief. |
Subscriber Tools: |
|
Advertising with SmartBrief: |
Healthcare Sales and Marketing Associate Rebecca Adelson 202-618-5665 |
Mailing Address: |
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 |
© 1999-2013 SmartBrief, Inc.® Legal Information. |
 |
|
没有评论:
发表评论